Drugs / FLUDIAZEPAM
FLUDIAZEPAM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01574313 Comparator | Apr 2010 → Apr 2011 | Meniere disease | Chi Mei Medical Hospital | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUDIAZEPAM | ChEMBL registry synonym — accepted as the source's own label CHEMBL13291 ↗ |
| Known as | erispan@ | “0.25mg of erispan@ (fludiazine), p.o. one dose only.” NCT01574313 ↗ |
| Known as | fludiazine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01574313 ↗ |
| Modality | Small molecule | — CHEMBL13291 ↗ |
| Route | Oral | “p.o. one dose only.” NCT01574313 ↗ |